{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380574093968630784.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Chi Chiu Mok"}],"foaf:familyName":[{"@value":"Mok"}],"foaf:givenName":[{"@value":"Chi Chiu"}]}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360574093968630784","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1093/ndt/gfw289"},{"@type":"URI","@value":"http://academic.oup.com/ndt/article-pdf/31/10/1561/6493286/gfw289.pdf"}],"notation":[{"@value":"Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/ndt/gfw289_KX2mg8c2E0oOzXg5ET0jOs4ob0M"}]}